Mylan-UpJohn merger as Viatris provides opportunity to focus on biosimilar launch and uptake EP News Bureau Mar 16, 2021 Following the news that the European Medicines Agency (EMA) has approved Kixelle, Biocon/Mylan’s biosimilar of Novo Nordisk’s…
Mylan and Pfizer’s Upjohn unveil logo and branding for Viatris EP News Bureau Jul 10, 2020 Announcement follows Mylan shareholder approval of Mylan’s combination with Pfizer’s Upjohn. Viatris is a new company that will be…
